drugset / Trial / NCT05037487

Evaluation of Smoked THC and CBD in Men and Women

NCT05037487

Phase 1 Completed 19 enrolled University of California, Los Angeles
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study is to determine the pharmacokinetics and pharmacodynamics of inhaled cannabis with varying amounts of delta-9-tetrahydrocannabinol (THC), and cannabidiol (CBD) and to evaluate detection of recently smoked THC in oral fluid.

Timeline

Start
2022-09-01
Primary completion
2025-01-07
Completion
2025-06-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 20 mg Inhaled
Subject delta-9-tetrahydrocannabinol Other / unclassified 20 mg Inhaled